UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 567

Sortiert nach

Single institution experience with neoadjuvant chemotherapy in stage IB2 cervical cancer in Peru

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e16505-e16505

Mas Lopez, Luis Alberto

2015

Volltextzugriff (PDF)

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy

Journal of clinical oncology, 2017-09, Vol.35 (26), p.3030-3038

2017

Volltextzugriff (PDF)

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

Journal of clinical oncology, 2015-11, Vol.33 (32), p.3788-3795

2015

Volltextzugriff (PDF)

Creative strategies to address challenges in access

Journal of clinical oncology, 2018-10, Vol.36 (30_suppl), p.215-215

2018

Volltextzugriff (PDF)

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update

Journal of clinical oncology, 2022-03, Vol.40 (8), p.892-910

2022

Volltextzugriff (PDF)

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

Journal of clinical oncology, 2019-02, Vol.37 (6), p.453-460

2019

Volltextzugriff (PDF)

First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.683-683

2023

Volltextzugriff (PDF)

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1112-1118

2017

Volltextzugriff (PDF)

Prognostic value of total tumor volume with 68Ga DOTATOC PET/CT in predicting response to 177-Lu-DOTATOC treatment in metastatic well-differentiated neuroendocrine tumors (NETs)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16248-e16248

2023

Volltextzugriff (PDF)

Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4358-4364

2007

Volltextzugriff (PDF)

Predictive Factors for Outcome in a Phase II Study of Gefitinib in Second-Line Treatment of Advanced Esophageal Cancer Patients

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1612-1619

2006

Volltextzugriff (PDF)

Impact of complete pathological response outcome in Latin American patients with rectal cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.58-58

2023

Volltextzugriff (PDF)

Clinical and prognostic utility of ALBI versus Child-Pugh score in a Mexican population with hepatocellular carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.517-517

2023

Volltextzugriff (PDF)

Increasing tobacco cessation counseling and referral in a statewide oncology collaborative

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.327-327

2022

Volltextzugriff (PDF)

Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic Adenocarcinoma

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3402-3408

2003

Volltextzugriff (PDF)

Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Journal of clinical oncology, 2013-05, Vol.31 (13), p.1624-1630

2013

Volltextzugriff (PDF)

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3337-3344

2012

Volltextzugriff (PDF)

Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A real-world experience

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.62-62

2023

Volltextzugriff (PDF)

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

Journal of clinical oncology, 2024-03, Vol.42 (9), p.1021

2024

Volltextzugriff (PDF)

Cost of oral cancer drugs: Trends in the United States Medicare population in 2013 and 2015

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.6631-6631

2019

Volltextzugriff (PDF)

Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5323-5333

2005

Volltextzugriff (PDF)

Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis

Journal of clinical oncology, 2006-08, Vol.24 (24), p.3823-3830

2006

Volltextzugriff (PDF)

METASNCore: A new tool for palliative whole brain radiotherapy (WBRT) assessment in the era of targeted therapies

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24154-e24154

2023

Volltextzugriff (PDF)

Prognostic Nutritional Index as a predictive factor of survival in patients with gastric cancer in a Mexican population

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.85-85

2019

Volltextzugriff (PDF)

1 – 25 von 567

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(567)
Mit Volltextzugriff
(565)

Publikationsform

Artikel
(567)

Sprache

Englisch
(567)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Oncology
(40)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(37)
Female
(28)
Middle Aged
(26)
Adult
(25)
Aged
(24)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Male
(18)
Tumors
(16)
Aged, 80 And Over
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Treatment Outcome
(9)
Disease-Free Survival
(8)
Original Reports
(8)
Chemotherapy, Adjuvant
(7)
Neoplasm Staging
(7)
Adolescent
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J Clin Oncol
(1)

Menü

Weitere Dienste

Einstellungen

Single institution experience with neoadjuvant chemotherapy in stage IB2 cervical cancer in Peru

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy

Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

Creative strategies to address challenges in access

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study

Prognostic value of total tumor volume with 68Ga DOTATOC PET/CT in predicting response to 177-Lu-DOTATOC treatment in metastatic well-differentiated neuroendocrine tumors (NETs)

Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer

Predictive Factors for Outcome in a Phase II Study of Gefitinib in Second-Line Treatment of Advanced Esophageal Cancer Patients

Impact of complete pathological response outcome in Latin American patients with rectal cancer

Clinical and prognostic utility of ALBI versus Child-Pugh score in a Mexican population with hepatocellular carcinoma

Increasing tobacco cessation counseling and referral in a statewide oncology collaborative

Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic Adenocarcinoma

Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A real-world experience

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

Cost of oral cancer drugs: Trends in the United States Medicare population in 2013 and 2015

Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer

Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis

METASNCore: A new tool for palliative whole brain radiotherapy (WBRT) assessment in the era of targeted therapies

Prognostic Nutritional Index as a predictive factor of survival in patients with gastric cancer in a Mexican population

Aktive Filter

Suchergebnisse filtern